Premium Nahrungsergänzungsmittel | artgerecht

Angiomyolipoma – Causes, Symptoms and Treatment

An angiomyolipoma is a benign kidney tumor composed of blood vessels, smooth muscle cells, and fat tissue. It is often found incidentally and may require treatment depending on its size.

Regular tips about health Regular tips about health

Things worth knowing about "Angiomyolipoma"

An angiomyolipoma is a benign kidney tumor composed of blood vessels, smooth muscle cells, and fat tissue. It is often found incidentally and may require treatment depending on its size.

What Is an Angiomyolipoma?

An angiomyolipoma is a benign (non-cancerous) tumor that most commonly develops in the kidney. It is composed of three tissue types: blood vessels (angio-), smooth muscle cells (myo-), and fat tissue (-lipoma). Because it contains all three components, it is also referred to as a triphasic tumor. Although benign, it can become dangerous due to growth or internal bleeding.

Prevalence and Risk Groups

Angiomyolipomas account for approximately 1–2% of all renal tumors. They occur in two main forms:

Sporadic form: The more common form, predominantly affecting middle-aged women with no underlying systemic disease.
Associated form: In approximately 20–30% of cases, the tumor is linked to a genetic condition called Tuberous Sclerosis Complex (TSC). In these patients, tumors tend to be bilateral, more numerous, and appear at a younger age.

Causes and Development

The exact cause of sporadic angiomyolipomas is not fully understood. Mutations in the mTOR signaling pathway -- a key regulator of cell growth -- are known to play a central role. In Tuberous Sclerosis Complex, mutations in the TSC1 or TSC2 genes lead to uncontrolled activation of this pathway, driving tumor growth.

Symptoms

Small angiomyolipomas are often asymptomatic and discovered incidentally during imaging for unrelated conditions. Larger tumors may cause:

Flank or back pain
Blood in the urine (hematuria)
A palpable abdominal mass
In severe cases: spontaneous internal bleeding (retroperitoneal hemorrhage), which is a medical emergency

The risk of hemorrhage increases significantly when the tumor exceeds 4 cm in diameter.

Diagnosis

Diagnosis is typically established through imaging studies:

Ultrasound: An initial screening tool; fat-containing tumors appear hyperechoic.
Computed Tomography (CT): The gold standard for diagnosis; reliably detects fat tissue within the tumor.
Magnetic Resonance Imaging (MRI): Particularly useful for fat-poor angiomyolipomas that may be difficult to characterize on CT.

A biopsy is usually not required but may be performed in cases of diagnostic uncertainty.

Treatment

Treatment depends on the size of the tumor, the presence of symptoms, and any underlying conditions:

Active Surveillance

For asymptomatic tumors smaller than 4 cm, regular monitoring with annual imaging is the recommended approach.

Medical Therapy

mTOR inhibitors such as everolimus can reduce tumor size and slow growth, and are particularly indicated in patients with Tuberous Sclerosis Complex.

Embolization

For tumors at risk of bleeding or causing symptoms, selective arterial embolization can be performed. This procedure blocks the blood supply to the tumor, causing it to shrink.

Surgical Removal

Surgery (partial nephrectomy or nephrectomy) is considered for very large tumors, recurrent bleeding, or diagnostically unclear lesions. Kidney-sparing procedures are preferred whenever possible.

Prognosis

The overall prognosis for angiomyolipoma is favorable. As a benign tumor, complete resolution is achievable with timely treatment. Regular follow-up imaging remains important to detect any recurrence or growth early.

References

Ljungberg B. et al. - EAU Guidelines on Renal Cell Carcinoma, European Association of Urology (2023)
Bissler J.J. et al. - Everolimus for Angiomyolipoma Associated with Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis, New England Journal of Medicine (2008)
WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th Edition, IARC Press (2016)

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category